<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties manuscript?><front><journal-meta><journal-id journal-id-type="nlm-journal-id">101231818</journal-id><journal-id journal-id-type="pubmed-jr-id">32150</journal-id><journal-id journal-id-type="nlm-ta">Mol Nutr Food Res</journal-id><journal-id journal-id-type="iso-abbrev">Mol Nutr Food Res</journal-id><journal-title-group><journal-title>Molecular nutrition &#x00026; food research</journal-title></journal-title-group><issn pub-type="ppub">1613-4125</issn><issn pub-type="epub">1613-4133</issn></journal-meta><article-meta><article-id pub-id-type="pmid">23650208</article-id><article-id pub-id-type="pmc">3810210</article-id><article-id pub-id-type="doi">10.1002/mnfr.201200801</article-id><article-id pub-id-type="manuscript">NIHMS515225</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>LC/MS characterization of rotenone induced cardiolipin oxidation in human lymphocytes: Implications for mitochondrial dysfunction associated with Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tyurina</surname><given-names>Yulia Y.</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><contrib contrib-type="author"><name><surname>Winnica</surname><given-names>Daniel E.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kapralova</surname><given-names>Valentina I.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kapralov</surname><given-names>Alexandr A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tyurin</surname><given-names>Vladimir A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kagan</surname><given-names>Valerian E.</given-names></name><xref ref-type="corresp" rid="CR1">*</xref></contrib><aff id="A1">Center for Free Radical and Antioxidant Health, Department of Environmental and Occupational Health, Graduate School of Public Health; University of Pittsburgh, Pittsburgh, PA 15219, USA</aff></contrib-group><author-notes><corresp id="CR1"><label>*</label>Correspondence: <underline>Yulia Y. Tyurina:</underline> Center for Free Radical and Antioxidant Health, Department of Environmental and Occupational Health, University of Pittsburgh, Bridgeside Point, 100 Technology Drive, Suite 350, Pittsburgh, PA; 15219; Phone: 412-383-5099; Fax: 412-624-9361; <email>yyt1@pitt.edu</email><underline>Valerian E. Kagan:</underline> Center for Free Radical and Antioxidant Health, Department of Environmental and Occupational Health, University of Pittsburgh, Bridgeside Point, 100 Technology Drive, Suite 350,Pittsburgh, PA; 15219; Phone: 412-624-9479; Fax: 412-624-9361; <email>kagan@pitt.edu</email></corresp></author-notes><pub-date pub-type="nihms-submitted"><day>18</day><month>9</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>03</day><month>5</month><year>2013</year></pub-date><pub-date pub-type="ppub"><month>8</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>8</month><year>2014</year></pub-date><volume>57</volume><issue>8</issue><fpage>1410</fpage><lpage>1422</lpage><!--elocation-id from pubmed: 10.1002/mnfr.201200801--><abstract><sec id="S1"><title>Scope</title><p id="P1">Rotenone is a toxicant believed to contribute to the development of Parkinson's disease.</p></sec><sec id="S2"><title>Methods and results</title><p id="P2">Using human peripheral blood lymphocytes we demonstrated that exposure to rotenone resulted in disruption of electron transport accompanied by the production of reactive oxygen species, development of apoptosis and elevation of peroxidase activity of mitochondria. Employing LC/MS based lipidomics/oxidative lipidomics we characterized molecular species of cardiolipin (CL) and its oxidation/hydrolysis products formed early in apoptosis and associated with the rotenone-induced mitochondrial dysfunction.</p></sec><sec id="S3"><title>Conclusions</title><p id="P3">The major oxidized CL species - tetra-linoleoyl-CL &#x02013; underwent oxidation to yield epoxy-C<sub>18:2</sub> and dihydroxy-C<sub>18:2</sub> derivatives predominantly localized in <italic>sn</italic>-1 and <italic>sn</italic>-2 positions, respectively. In addition, accumulation of mono-lyso-CL species and oxygenated free C<sub>18:2</sub> were detected in rotenone-treated lymphocytes. These oxidation/hydrolysis products may be useful for the development of new biomarkers of mitochondrial dysfunction.</p></sec></abstract><kwd-group><kwd>Cardiolipin peroxidation</kwd><kwd>lymphocytes</kwd><kwd>apoptosis</kwd><kwd>mitochondrial dysfunction</kwd><kwd>Parkinson's disease biomarkers</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="S4"><title>Introduction</title><p id="P4">Parkinson's disease (PD) is a neurodegenerative disorder in the elderly resulting in the damage and death of dopaminergic neurons in the brain [<xref rid="R1" ref-type="bibr">1</xref>]. Oxidative stress and mitochondrial dysfunction have been implicated as important contributors to neuronal death induced in <italic>substantia nigra</italic> of patients with PD [<xref rid="R2" ref-type="bibr">2</xref>&#x02013;<xref rid="R4" ref-type="bibr">4</xref>]. In particular, increased lipid peroxidation products have been found in PD brains [<xref rid="R5" ref-type="bibr">5</xref>]. During the last three decades, epidemiological and toxicological studies provided data that pesticides are potential toxicants for dopamine-producing neurons and contribute to the development of PD [<xref rid="R6" ref-type="bibr">6</xref>]. Accordingly, exposure to pesticides has been associated with increased incidence of PD [<xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R8" ref-type="bibr">8</xref>]. Mitochondria are targets for a number of environmental compounds including pesticides [<xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref>] such as rotenone [<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>]. Rotenone is highly lipophillic, easily crosses the blood-brain barrier and accumulates in mitochondria where it binds to complex I, inhibits the flow of electrons and results in generation of superoxide [<xref rid="R11" ref-type="bibr">11</xref>]. However, the mechanistic links between the oxidative stress, lipid peroxidation, neuronal death, mitochondrial impairments induced by pesticides have not been identified.</p><p id="P5">Blood cells and circulating lymphocytes have been often used to study the pathogenic mechanisms of neurodegenerative diseases, including PD. Mitochondrial complex deficit [<xref rid="R12" ref-type="bibr">12</xref>, <xref rid="R13" ref-type="bibr">13</xref>] and up-regulation of the &#x003b1;-synuclein gene [<xref rid="R14" ref-type="bibr">14</xref>] that render these cells susceptible to apoptosis were detected in lymphocytes from PD patients [<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Recently, we demonstrated that oxidation of a mitochondria-specific phospholipid, cardiolipin (CL), is essential for the execution of apoptosis (release of proapoptotic factors from mitochondria into the cytosol) in primary rat cortical neurons <italic>in vitro</italic> [<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R18" ref-type="bibr">18</xref>] and in rat brain <italic>in vivo</italic> [<xref rid="R19" ref-type="bibr">19</xref>, <xref rid="R20" ref-type="bibr">20</xref>]. Intermembrane space hemoprotein, cytochrome <italic>c</italic> (cyt <italic>c</italic>) has been identified as a catalyst of CL peroxidation [<xref rid="R21" ref-type="bibr">21</xref>]. CL is a negatively charged phospholipid with four fatty acid residues [<xref rid="R21" ref-type="bibr">21</xref>]. It is found exclusively in the inner-mitochondrial membrane where it accounts for 25% of all phospholipids [<xref rid="R22" ref-type="bibr">22</xref>] and plays a significant role in mitochondria bioenergetics [<xref rid="R23" ref-type="bibr">23</xref>&#x02013;<xref rid="R26" ref-type="bibr">26</xref>]. Taking into account that lymphocytes express the catecholaminergic system and, similar to neuronal cells, molecular death machinery, including the release of mitochondrial pro-apoptotic factors into the cytosol, leading to the typical morphological and biochemical characteristics of apoptosis [<xref rid="R27" ref-type="bibr">27</xref>&#x02013;<xref rid="R29" ref-type="bibr">29</xref>], we suggested that cyt c can be involved in the generation of specifically oxygenated molecular species of CL in circulating lymphocytes exposed to rotenone.</p><p id="P6">In this paper, by using lipidomics/oxidative lipidomics approaches we identified and characterized molecular species of CL in human peripheral blood lymphocytes, evaluated specific profiles of rotenone-induced CL oxidation products and established their association with the production of H<sub>2</sub>O<sub>2</sub>, impairments of mitochondrial dysfunction and apoptosis in human lymphocytes exposed to rotenone.</p></sec><sec sec-type="methods" id="S5"><title>Material and Methods</title><sec id="S6"><title>Reagents</title><p id="P7">Tetra-linoleyl-cardiolipin (TLCL) and tetra-myristoyl-cardiolipin (TMCL) were purchased from Avanti Polar Lipids Inc (Alabaster, AL). Cytochrome <italic>c</italic> (cyt <italic>c</italic>), diethylenetriaminepentaacetic acid (DTPA), PLA<sub>1</sub> from <italic>Thermomyces lanuginosus</italic>, PLA<sub>2</sub> from porcine pancreas, H<sub>2</sub>O<sub>2</sub> and all organic solvents (HPLC grade), Hystopaque 1077, PBS (Ca<sup>2+</sup>, Mg<sup>2+</sup> free), rotenone, DMSO were purchased from Sigma-Aldrich (St. Louis, MO). HPTLC silica G plates were purchased from Whatman (Schleicher &#x00026; Schuell, England). Fetal bovine serum, RPMI 1640 medium Penicillin/Streptomycin were from Life Technologies (Grand Island, NY). Heptadecanoic acid (C<sub>17:0</sub>) was obtained from Matreya LLC (Pleasant Gap, PA). 9S-hydroperoxy-10E,12Z-octadecadienoic acid, 9S-hydroxy-10E,12Z-octadecadienoic acid, 13-oxo-9Z,11E-octadecadienoic acid, 13S-hydroxy-9Z,11E-octadecadienoic acid, 13S-hydroperoxy-9Z,11E-octadecadienoic acid, 9S-hydroxy-10E,12Z-octadecadienoic-9,10,12,13-d<sub>4</sub> acid, 9(10)epoxy-12Z-octadecenoic acid, 12(13)epoxy-9Z-octadecenoic acid were purchased from Cayman Chemical Co (Ann Arbor, Michigan, USA).</p><sec id="S7"><title>Isolation of human peripheral blood lymphocytes</title><p id="P8">Lymphocytes were isolated from buffy coat obtained from Central Blood Bank by differential centrifugation using Hystopaque 1077 as described [<xref rid="R30" ref-type="bibr">30</xref>].</p></sec><sec id="S8"><title>Production of reactive oxygen species</title><p id="P9"><italic>Superoxide and hydrogen peroxide</italic> were detected by using dihydroethidium (DHE) and 2',7'-dichlorfluorescein-diacetate (DCFH-DA) assays, respectively, as previously described [<xref rid="R31" ref-type="bibr">31</xref>]. The data are presented as fold change of the mean intensity of either ethidium or DCF fluorescence compared with DHE or DCFH-DA loaded controls for superoxide and hydrogen peroxide, respectively.</p></sec><sec id="S9"><title>Detection of apoptosis</title><p id="P10">Apoptosis was evaluated by phosphatidylserine (PS) externalization using Annexin V&#x02013;FITC apoptosis detection kit (Biovision, Mountain View, CA) and caspase 3/7 with a luminescence Caspase&#x02013;Glo&#x02122; 3/7 assay kit (Promega, Madison, WI).</p></sec><sec id="S10"><title>Assessments of mitochondrial functional state</title><p id="P11"><italic>Mitochondrial membrane potential</italic> (MMP) was determined by JC-1 staining. Briefly, lymphocytes were stained with 10 &#x003bc;g/ml of JC-1 at 37 &#x000b0;C for 15 min and then washed twice with PBS. The samples were analyzed immediately by using RF-5301 PC spectrofluorometer (Shimadzu. Japan) (excitation 485 nm, slits 5 nm). The ratio of red (aggregates, 590 nm) and green (monomer, 529 nm) fluorescence was used as a relative measure of MMP. In addition the lymphocytes were examined under a Nikon ECLIPSE TE 200 fluorescence microscope (Tokyo, Japan) equipped with a digital Hamamatsu CCD camera (C4742-95-12NBR) and analyzed using the MetaImaging Series&#x02122; software version 4.6 (Universal Imaging Corp., Downingtown, PA). <italic>Cellular ATP</italic> content was measured by using an adenosine 5'-triphosphate bioluminescence somatic cell assay kit (Sigma) according to the manufacturer's instructions. <italic>Complex I activity</italic> was measured by consumption of NADH at 340nm as described [<xref rid="R32" ref-type="bibr">32</xref>].</p></sec><sec id="S11"><title>Isolation of mitochondria and detection of peroxidase activity</title><p id="P12">Mitochondria were isolated from human peripheral blood lymphocytes as described [<xref rid="R33" ref-type="bibr">33</xref>]. Peroxidase activity was detected as previously described [<xref rid="R34" ref-type="bibr">34</xref>]. Briefly mitochondria (2 mg of protein/ml) were incubated with alamethicin (0.1 mg/ml) on ice for 15 min in 150 mM KCl, 0.5 mM EGTA, 25 mM KH<sub>2</sub>PO4 (pH 7.0). After that mitochondria were centrifuged (15,000g for 15 min) and re-suspended in 25 mM HEPES (pH 7.4) containing 100 &#x003bc;M DTPA, Amplex Red (50 &#x003bc;M) and <italic>tert</italic>-BOOH (2 mM). Fluorescence of resorufin, a product of Ample Red oxidation, was measured using Shimadzu RF5301&#x02013;PC spectrofluorometer (&#x003bb;<sub>ex</sub> and &#x003bb;<sub>em</sub> &#x02212; 575 and 585 nm, respectively).</p></sec><sec id="S12"><title>Analysis of CL and its oxygenated molecular species</title><p id="P13">Lipids were extracted using Folch procedure [<xref rid="R35" ref-type="bibr">35</xref>]. Lipid phosphorus was determined by a micro-method [<xref rid="R36" ref-type="bibr">36</xref>]. LC/MS was performed using a Dionex Ultimate&#x02122; 3000 HPLC system coupled on-line to a linear ion trap mass spectrometer (LXQ Thermo-Fisher) as described [<xref rid="R37" ref-type="bibr">37</xref>]. To fully characterize oxygenated free fatty acids and diversified CL oxidation products we chose to pre-separate them from other phospholipids by 2D-HPTLC as previously described [<xref rid="R38" ref-type="bibr">38</xref>]. Corresponding spots were scraped-off and lipids extracted [<xref rid="R35" ref-type="bibr">35</xref>]. Thus obtained CLs were treated either with phospholipase A<sub>1</sub> (PLA<sub>1</sub>) from <italic>Thermomyces lanuginosus</italic> or PLA<sub>2</sub> from porcine pancreatic phospholipase A<sub>2</sub> (PLA<sub>2</sub>) to liberate fatty acids from <italic>sn</italic>-1 and <italic>sn</italic>-2 positions and analyzed by LC-MS. Briefly, CLs were treated with PLA<sub>1</sub> (10 &#x003bc;l/&#x003bc;mol CL) or PLA<sub>2</sub> (10U/&#x003bc;mol of CL) in 0.5 M borate buffer, pH 9.0 containing 20 mM cholic acid, 2 mM CaCl<sub>2</sub> and 100 &#x003bc;M DTPA for 30 min. Under these conditions, almost 99% of CLs were hydrolyzed. At the end of incubation, lipids were extracted and fatty acids were analyzed by LC/MS using reverse phase C<sub>18</sub> column. The differentiation between isobaric epoxy-C<sub>18:2</sub> CL species from hydroxy-C<sub>18:2</sub>-containing species was achieved via i) treatment of CLs by exogenous PLA<sub>1</sub>/PLA<sub>2</sub> resulting in the release of LA residues and ii) their subsequent separation and analysis by LC-MS using C<sub>18</sub> column and two gradient solvent systems (system A: tetrahydrofuran/methanol/water/CH<sub>3</sub>COOH, 25:30:44.9:0.1 (v/v) and System B: methanol/water, 90:10 (v/v)) as previously described [<xref rid="R39" ref-type="bibr">39</xref>]. Under these conditions, the retention times for epoxy-C<sub>18:2</sub> (m/z 295) and hydroxy-C<sub>18:2</sub> (m/z 295) were 21.16 and 17.04 min, respectively. This was confirmed by comparison with the standards of epoxy-C<sub>18:2</sub> (m/z 295) and hydroxy-C<sub>18:2</sub> (m/z 295) available from Cayman Chemicals. Additionally, several major classes of phospholipids, including CLs, were separated and analyzed by LC-MS as described [<xref rid="R37" ref-type="bibr">37</xref>]. For quantitative assessments TMCL and oxygenated fatty acids were used as internal standards. Mono-lyso-CL was prepared from TMCL as described [<xref rid="R40" ref-type="bibr">40</xref>].</p></sec><sec id="S13"><title>Statistics</title><p id="P14">The results are presented as mean &#x000b1; S.D. values from at least three experiments, and statistical analyses were performed by either paired/unpaired Student's t-test or one-way ANOVA. The statistical significance of differences was set at p&#x0003c; 0.05.</p></sec></sec></sec><sec sec-type="results" id="S14"><title>Results</title><sec id="S15"><title/><sec id="S16"><title>Rotenone induces mitochondria dysfunction in human lymphocytes</title><p id="P15">After exposure of human peripheral blood lymphocytes to rotenone (100 and 250 &#x003bc;M, 12 and 18 hrs at 37&#x000b0;C), the mitochondrial functions were assessed by measurements of MMP, determination of complex I activity and ATP levels. Rotenone induced significant inhibition of complex I activity in a dose- and time dependent manners (<xref ref-type="fig" rid="F1">Fig 1A</xref>). Significant reductions of the MMP and ATP contents were detected in lymphocytes treated with rotenone (<xref ref-type="fig" rid="F1">Fig.1B, C</xref>). Thus exposure of human lymphocytes to rotenone resulted in disruption of electron transport and mitochondrial dysfunction.</p></sec><sec id="S17"><title>Generation of reactive oxygen species in human lymphocytes exposed to rotenone</title><p id="P16">Interrupted mitochondrial electron transport, particularly at the level of complex I, is known to cause a massive production of superoxide (53). To determine whether superoxide, indeed, has been generated in rotenone-treated cells we used DHE assay. We found that rotenone caused concentration-dependent production of superoxide (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Given that mitochondrial superoxide is rapidly converted to membrane permeable and relatively stable hydrogen peroxide we examined the intracellular concentration of hydrogen peroxide using DCFH-DA assay. A significant increase of DCF fluorescence was observed in human lymphocytes following rotenone exposure (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). Thus, rotenone-induced mitochondria dysfunction in lymphocytes was accompanied by the production of ROS.</p></sec><sec id="S18"><title>Rotenone induces apoptosis in human lymphocytes</title><p id="P17">Assuming that generation of ROS is one of the pre-requisites for triggering apoptosis, we further determined whether rotenone-induced production of superoxide and H<sub>2</sub>O<sub>2</sub> was accompanied by apoptosis. Indeed, we found that caspase 3/7 activity was significantly increased in lymphocytes exposed to rotenone as compared with control non-exposed lymphocytes (<xref ref-type="fig" rid="F3">Fig. 3A</xref>). A 2.5 and 2.8-fold increase in caspase 3/7 activity was detected either for 12 or 18 hrs after the exposure to 100 and 250 &#x003bc;M of rotenone, respectively. In addition, using Annexin V binding assay we were able to detect a significant number of lymphocytes with externalized PS on the cell surface after their exposure to 100 and 250 &#x003bc;M of rotenone for 12 and 18 hrs (<xref ref-type="fig" rid="F3">Fig. 3B</xref>). Thus, treatment of lymphocytes to rotenone resulted in development of apoptotic cell death pathway.</p></sec><sec id="S19"><title>Rotenone stimulates peroxidase activity in mitochondria</title><p id="P18">We suggested that in lymphocytes, during rotenone-induced apoptosis, mitochondrial phospholipid CL interacts with cyt <italic>c</italic> to form a complex with peroxidase activity that consequently results in selective oxidation of CL polyunsaturated molecular species. To detect peroxidase activity of cyt <italic>c</italic>/CL complexes we isolated mitochondria from lymphocytes exposed to rotenone. To remove free cyt <italic>c</italic> we treated mitochondria with a channel-forming antibiotic, alamethicin (9). Notably, mitochondria isolated from lymphocytes exposed to rotenone at concentrations of 100 and 250 &#x003bc;M for 18 hrs exhibited significantly elevated levels of peroxidase activity as compared to mitochondria from control, non-treated lymphocytes (<xref ref-type="fig" rid="F4">Fig. 4</xref>).</p></sec><sec id="S20"><title>Identification of CL molecular species in human lymphocytes</title><p id="P19">As CL oxidation is required for the execution of apoptotic program, we further employed LC/MS to analyze CL molecular species and their oxidation products in lymphocytes. In a typical negative mode MS spectrum of CL, two major clusters were detected (<xref ref-type="fig" rid="F5">Fig. 5A</xref>). MS/MS analysis was performed (<xref ref-type="supplementary-material" rid="SD1">Supporting Information Fig. S1</xref>) showed that CLs were represented by seven major molecular species predominantly containing readily peroxidizable linoleic acid residues (C<sub>18:2</sub>) (<xref ref-type="table" rid="T1">Table 1</xref>).</p></sec><sec id="S21"><title>Identification of CL molecular species in human lymphocytes exposed to rotenone</title><p id="P20">Next, we performed detailed structural characterization of oxygenated CL molecular species in human peripheral blood lymphocytes. Quantitative assessments of rotenone-induced changes in CL revealed a significant reduction of highly unsaturated species of CL, particularly TLCL (<xref ref-type="fig" rid="F5">Fig. 5B</xref>). The loss of &#x0201c;oxidizable&#x0201d; TLCL was dependent on concentration of rotenone and accompanied by the appearance of its oxygenated species with one, two and three oxygen functionalities whereby mono-oxygenated derivatives were predominant (<xref ref-type="fig" rid="F5">Fig. 5C</xref>). The structure of oxygenated CLs was confirmed by MS/MS analysis as exemplified by a typical fragmentation pattern of mono-oxygenated TLCL molecular (<xref ref-type="supplementary-material" rid="SD1">Supporting Information Fig. S2</xref>).</p><p id="P21">Stereo-specificity of TLCL oxygenation in <italic>sn</italic>-1 and <italic>sn</italic>-2 positions was examined by LC/ESI-MS using hydrolysis of CL with PLA<sub>1</sub> and/or PLA<sub>2</sub>, respectively. Quantitative MS analysis of fatty acids liberated from <italic>sn</italic>-1 position revealed a significantly decreased C<sub>18:2</sub> content (<xref ref-type="fig" rid="F6">Fig. 6Aa</xref>) and elevated levels of its oxygenated product with 1&#x02013;3 oxygens (<xref ref-type="fig" rid="F6">Fig. 6Ab</xref>) that markedly exceeded oxidative loss of C<sub>18:2</sub> from the sn-2 position (<xref ref-type="fig" rid="F6">Fig. 6Ba</xref>). Notably, the major oxygenated differences between oxygenated products generated in <italic>sn</italic>-1 and <italic>sn</italic>-2 positions were not only quantitative but also qualitative with epoxy-C<sub>18:2</sub> derivatives (<xref ref-type="fig" rid="F6">Fig. 6Ab</xref> and <xref ref-type="supplementary-material" rid="SD1">Supporting Information Fig.S3</xref>) and dihydroxy-C<sub>18:2</sub> derivatives (<xref ref-type="fig" rid="F6">Fig. 6Bb</xref> and <xref ref-type="supplementary-material" rid="SD1">Supporting Information Fig. S4</xref>) accumulating in <italic>sn</italic>-1 and <italic>sn</italic>-2 positions, respectively.</p><p id="P22">To test whether cyt <italic>c</italic> could be a candidate catalyst involved in rotenone-induced generation of oxygenated molecular species of CL, we performed a model oxidation experiment using TLCL, the major molecular species of CL present in human peripheral blood lymphocytes (<xref ref-type="fig" rid="F4">Fig. 4A</xref>, <xref ref-type="table" rid="T1">Table 1</xref>). When TLCL was incubated in the presence of cyt <italic>c</italic> and hydrogen peroxide for 30 min at 37&#x000b0;C we found that a decreased content of TLCL was accompanied by the accumulation of its oxygenated products with 1&#x02013;3 oxygens with similar composition and stereo-specificity as those detected in rotenone-exposed lymphocytes (<xref ref-type="fig" rid="F7">Fig. 7A, B</xref>). These results are compatible with involvement of cyt <italic>c</italic> in catalysis of TLCL oxidation in lymphocytes exposed to rotenone.</p></sec><sec id="S22"><title>Rotenone induced accumulation of mono-lyso-CL in human lymphocytes</title><p id="P23">It is possible that the loss of CL in rotenone-challenged lymphocytes may be associated, at least in part, with activation of endogenous PLA<sub>2</sub>. The presence of Ca<sup>2+</sup>-independent iPLA<sub>2</sub> in capable of utilizing (oxidatively modified) CL species in mitochondria has been reported [<xref rid="R41" ref-type="bibr">41</xref>&#x02013;<xref rid="R43" ref-type="bibr">43</xref>]. Indeed, treatment of lymphocytes with rotenone resulted in increased content of mono-lyso-CL species (<xref ref-type="fig" rid="F8">Fig. 8A</xref>). In line with this accumulation of oxygenated C<sub>18:2</sub> containing from one to three oxygens in the fraction of free fatty acids was detected (<xref ref-type="fig" rid="F8">Fig. 8B</xref>). After rotenone exposure, the endogenous contents of mono-lyso-CL and free fatty acids &#x02013; likely released from phospholipids by endogenous PLA<sub>2</sub> - are shown in <xref ref-type="fig" rid="F8">Figs. 8Ab and 8Bb</xref>. We found that the content of free C<sub>18:2</sub> with two oxygens (m/z 311) was higher than that of mono-oxygenated C<sub>18:2</sub>. This suggests that endogenous PLA<sub>2</sub> &#x02013; likely mitochondrial iPLA<sub>2</sub> &#x02013; hydrolyzed peroxidized TLCLs with two oxygens (m/z 311) more effectively than CLs with mono-oxygenated C<sub>18:2</sub> (m/z 295). No significant accumulation of other lyso-phospholipids in lymphocytes in response to rotenone was detected (data not shown). This suggests that accumulated mono-lyso-CL molecular species originated from oxygenated TLCL formed in lymphocytes upon rotenone exposure.</p></sec></sec></sec><sec sec-type="discussion" id="S23"><title>Discussion</title><p id="P24">Although oxygenated fatty acids and phospholipids are critical signaling molecules (and/or biomarkers) in several neurological disorders [<xref rid="R44" ref-type="bibr">44</xref>], essential information on molecular targets, particularly specific polyunsaturated molecular species of phospholipids undergoing oxidation and leading to mitochondrial dysfunction and their association with neurodegenerative disease such as PD, is lacking. While the general association of oxidative stress with PD has been emphasized in numerous studies (reviewed in [<xref rid="R45" ref-type="bibr">45</xref>&#x02013;<xref rid="R48" ref-type="bibr">48</xref>], attempts to link the products of oxidative modification of different biomolecules to specific pathogenetic pathways of PD were not victorious [<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R49" ref-type="bibr">49</xref>]. This may be due, at least in part, to insufficient information on the diversity and structure of oxidized biomolecules generated in mitochondria &#x02013; the major metabolic candidate as a source of impaired and oxidatively modified PD-associated molecular species. Among those, CLs &#x02013; unique and functionally essential phospholipids of mitochondria &#x02013; may be of particular importance [<xref rid="R50" ref-type="bibr">50</xref>&#x02013;<xref rid="R52" ref-type="bibr">52</xref>]. In this paper by using LC/MS-based oxidative lipidomics, we characterized all major molecular species of CL and its oxidized molecular species formed in rotenone-associated dysfunctional mitochondria in human peripheral blood lymphocytes.</p><p id="P25">Changes in the CL content as well as its composition have been shown to be responsible for mitochondrial dysfunction associated with several pathological conditions [<xref rid="R53" ref-type="bibr">53</xref>&#x02013;<xref rid="R56" ref-type="bibr">56</xref>]. CL profile in mitochondria can be changed due to: i) loss of CL as a result of alteration in CL synthase activity [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R57" ref-type="bibr">57</xref>], ii) altered fatty acid composition of CL as a result of disruption of CL remodeling process [<xref rid="R58" ref-type="bibr">58</xref>&#x02013;<xref rid="R60" ref-type="bibr">60</xref>] and, iii) CL oxidation due to ROS generation [<xref rid="R55" ref-type="bibr">55</xref>]. Generation of ROS [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R61" ref-type="bibr">61</xref>] and activation of the intrinsic apoptotic cell death pathway [<xref rid="R62" ref-type="bibr">62</xref>] have been associated with rotenone-induced neuron degeneration <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="R53" ref-type="bibr">53</xref>&#x02013;<xref rid="R55" ref-type="bibr">55</xref>], dissipation of MMP, release cyt <italic>c</italic> from mitochondria into the cytosol and apoptosis [<xref rid="R63" ref-type="bibr">63</xref>]. Chronic and systemic inhibition of complex I leads to selective degeneration of dopaminergic neurons and produces neuro-pathological features of PD [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R64" ref-type="bibr">64</xref>].</p><p id="P26">Having in mind potential detection of mitochondrial phospholipid biomarkers of PD, we examined human peripheral blood lymphocytes that are often used to identify the mechanism leading to development of neurodegenerative diseases such as PD and Alzheimer disease [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R65" ref-type="bibr">65</xref>, <xref rid="R66" ref-type="bibr">66</xref>]. In fact, increased apoptosis of lymphocytes in patients with PD has been documented [<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Both extrinsic and intrinsic apoptotic pathways were recognized in lymphocytes of PD patients [<xref rid="R16" ref-type="bibr">16</xref>, <xref rid="R67" ref-type="bibr">67</xref>, <xref rid="R68" ref-type="bibr">68</xref>]. Notably, rotenone induced apoptosis in lymphocytes has been linked to its ability to generate ROS (<inline-formula><mml:math display="inline" id="M1" overflow="scroll"><mml:mrow><mml:msup><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mover accent="true"><mml:mo>&#x02212;</mml:mo><mml:mo>.</mml:mo></mml:mover></mml:msup><mml:mo>&#x02215;</mml:mo><mml:msub><mml:mi mathvariant="normal">H</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">O</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula>) leading to mitochondrial damage [<xref rid="R10" ref-type="bibr">10</xref>]. Further rotenone-induced inhibition of complex I activity and impairment of electron transport leading to massive production of ROS [<xref rid="R69" ref-type="bibr">69</xref>], and possibly protein and lipid peroxidation have been documented in dopaminergic cell line using BODYPI oxidation assays [<xref rid="R70" ref-type="bibr">70</xref>]. However, specific features of CL peroxidation and identification of CL oxidation products as essential factors in mitochondrial stages of lymphocyte apoptosis, have not been studied so far.</p><p id="P27">Here, we demonstrated that exposure of human lymphocytes to rotenone is associated with mitochondria dysfunction, ROS production, development of apoptotic cell death pathway and accumulation of oxygenated species of highly unsaturated CL containing four C<sub>18:2</sub> residues as well as its metabolite mono-lyso-CL. Detailed structural analysis of CL oxidation products revealed unusual features of rotenone-triggered peroxidation: i) predominant peroxidation of TLCL, CL containing four C<sub>18:2</sub> residues ii) preferential accumulation of oxygenated C<sub>18:2</sub> in <italic>sn</italic>-1 rather than <italic>sn</italic>-2 position; iii) quantitative abundance of mono-oxygenated species <italic>vs</italic> species with two and three oxygen functionalities. Further studies will determine whether these specific features are uniquely associated with the rotenone-driven inhibition of respiratory complex I or may be common to other oxidative routes leading to the execution of apoptotic program in lymphocytes.</p><p id="P28">Our previous work has identified cyt <italic>c</italic>, an intermembrane space electron carrier, as a catalyst of the reaction during which it binds CL to yield a complex with CL-specific peroxidase activity [<xref rid="R34" ref-type="bibr">34</xref>]. The complex generates oxygenated CL species at the early stage of apoptosis <italic>in vitro</italic> and <italic>in vivo</italic> [<xref rid="R17" ref-type="bibr">17</xref>, <xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R37" ref-type="bibr">37</xref>, <xref rid="R71" ref-type="bibr">71</xref>, <xref rid="R72" ref-type="bibr">72</xref>]. Moreover, cyt <italic>c</italic>/CL complexes can interact with &#x003b1;-synuclein to form oligomers with high peroxidase activity [<xref rid="R52" ref-type="bibr">52</xref>] thus contributing to the formation of Lewis bodies &#x02013; a morphological hallmark of PD. These results provided direct evidence for previously suggested conversion of cyt c into peroxidase and its possible role in neurodegenerative process [<xref rid="R73" ref-type="bibr">73</xref>], including pathogenesis of PD [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>]. Notably, while peroxidase activity cyclooxygenase-2 and peroxidation of non-esterified fatty acids have been linked to the pathogenesis of PD [<xref rid="R74" ref-type="bibr">74</xref>, <xref rid="R75" ref-type="bibr">75</xref>] the oxidation of esterified lipids has not been yet investigated. Our data indicate that in rotenone treated lymphocytes, cyt <italic>c</italic> utilizes ROS, particularly hydrogen peroxide, formed during apoptotic cell death, to cause peroxidation of C<sub>18:2</sub>-containing CL species in mitochondria (<xref ref-type="fig" rid="F9">Fig. 9</xref>). In addition, rotenone-induced oxidative stress and ROS production can cause activation of Ca<sup>2+</sup>-independent iPLA<sub>2</sub> [<xref rid="R76" ref-type="bibr">76</xref>] resulting in the accumulation of CL hydrolysis products such as mono-lyso-CL and oxygenated fatty acids. iPLA<sub>2</sub> has been identified as the major endogenous type of PLA<sub>2</sub> capable of hydrolyzing peroxidized phospholipids in mitochondria [<xref rid="R41" ref-type="bibr">41</xref>, <xref rid="R77" ref-type="bibr">77</xref>].</p><p id="P29">We found that the most predominant molecular species of CL that underwent oxidative modification after exposure of human lymphocytes to rotenone was tetralinoleoyl-CL with four symmetric C<sub>18:2</sub>-residues in both <italic>sn</italic>-1 and <italic>sn</italic>-2 positions. In addition we were able to detect endogenously formed TLCLox, non-ox-mono-lyso-CL and C<sub>18:2</sub>-ox. To determine which of C<sub>18:2</sub> residues was a preferred substrate of rotenone-induced peroxidation, we treated isolated CL fraction with either PLA<sub>1</sub> or PLA<sub>2</sub> &#x02013; to produce lyso-CLs and release C<sub>18:2</sub> from the respective <italic>sn</italic>-1 or <italic>sn</italic>-2 positions. This resulted in liberation of oxygenated C<sub>18:2</sub> species and di-lyso-CLs whereby higher contents of oxygenated C<sub>18:2</sub> was produced by PLA<sub>1</sub> (as compared to PLA<sub>2</sub>). Because 99% of total CLs were hydrolyzed and converted into di-lyso-CLs and FAs, we further analyzed oxygenated species of C<sub>18:2</sub>. We found that only one out of four C<sub>18:2</sub> in TLCL molecule (in either <italic>sn</italic>-1 or <italic>sn</italic>-2 positions) underwent oxidative modification upon rotenone exposure. Assuming that endogenous iPLA<sub>2</sub> cleaves predominantly C<sub>18:2</sub>-ox in sn-2 but not non-ox-C<sub>18:2</sub>, C<sub>18:2</sub>-ox plus non-ox-mono-lyso-CL should be expected hydrolysis products &#x02013; in line with our observations. Thus not only CL peroxidation products but also mono-lyso-CL in lymphocytes may be used as biomarkers of PD-associated metabolic disturbances &#x02013; similar to recent finding in patients with Barth syndrome, a disease associated with mitochondrial dysfunction [<xref rid="R78" ref-type="bibr">78</xref>].</p><p id="P30">While this study has been focused on CLs as well as their oxidized and hydrolyzed metabolites, we have also analyzed several other major classes of phospholipids, such as phosphatidylcholine, phosphatidylethanolamine, phopshatidylinositol, phosphatidylserine and sphingomyelin. We found that exposure of lymphocytes to rotenone resulted in significant accumulation of several oxygenated molecular species of TLCL as well as its hydrolysis products &#x02013; mono-lyso-CL and oxygenated free C<sub>18:2</sub>. These rotenone-induced changes were CL-specific: neither oxygenated products nor hydrolysis products were detected in other examined classes of phospholipids. Thus no rotenone-induced remodeling of other phospholipids took place under experimental conditions used.</p><p id="P31">Apoptotic cell death pathway is activated in lymphocytes of PD patients [<xref rid="R15" ref-type="bibr">15</xref>, <xref rid="R16" ref-type="bibr">16</xref>]. Therefore, peripheral blood lymphocytes are considered as potential candidate-biomarkers of mitochondrial dysfunction in PD. Given a recently established role of selective peroxidation of a mitochondria-specific phospholipid, CL, in execution of mitochondrial stages of apoptosis, one can assume that detailed analysis of CL peroxidation products may lead to the development of useful biomarkers. It has been reported that micromolar concentrations of rotenone (10&#x02013;250 &#x003bc;M) induce apoptosis in isolated human lymphocytes [<xref rid="R10" ref-type="bibr">10</xref>]. However, specific role of CL peroxidation as an essential factor in mitochondrial stages of lymphocyte apoptosis, has not been yet studied. In the current work, we found that rotenone (at concentrations of 100 and 250 &#x003bc;M) was effective in stimulating selective accumulation of CL oxidation products and induction of apoptosis in isolated human lymphocytes. While the concentrations of rotenone used may seem to be relatively high, one should consider them in the context of its known toxicity and exposure doses. The estimates of rotenone toxicity for humans are commonly based on animal studies. In rat rotenone PD model with administration of pesticide through I.V. route (3&#x02013;18 mg/kg/day) [<xref rid="R79" ref-type="bibr">79</xref>, <xref rid="R80" ref-type="bibr">80</xref>], its concentration in circulation is within micromolar range. Of note, rotenone is usually sold as 1 &#x02013; 5% formulation that corresponds to approximately its 30&#x02013;150 mM solution. Thus agricultural workers can be occupationally exposed to relatively high doses of rotenone.</p><p id="P32">In conclusion, we demonstrated that exposure of human peripheral blood lymphocytes to a pesticide, rotenone, causes time- and dose-dependent selective oxidation of TLCL, accumulation of its hydrolysis products - mono-lyso-CLs - as well as generation of TLCL oxygenated molecular species associated with mitochondrial dysfunction likely through enzymatic cyt <italic>c</italic> catalyzed reactions triggered early in apoptosis. We believe that characterization of oxidatively modified CL molecular species as well as identification its hydrolysis products are important for better understanding of PD pathogenesis and may lead to the development of new biomarkers of mitochondrial dysfunction associated with PD.</p></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Supplementary Figures</label><media xlink:href="NIHMS515225-supplement-Supplementary_Figures.pptx" mimetype="application" mime-subtype="octet-stream" orientation="portrait" xlink:type="simple" id="d36e1090" position="anchor"/></supplementary-material></sec></body><back><ack id="S24"><p>Supported by NIH: ES020693, HL70755, U19AIO68021; by NIOSH OH008282.</p></ack><fn-group><fn id="FN1"><p id="P33">The authors have declared no conflict of interest.</p></fn></fn-group><glossary><title>Abbreviations</title><def-list><def-item><term>CL</term><def><p>cardiolipin</p></def></def-item><def-item><term>cyt <italic>c</italic></term><def><p>cytochrome <italic>c</italic></p></def></def-item><def-item><term>DCFH-DA</term><def><p>2',7'-dichlorfluorescein-diacetate</p></def></def-item><def-item><term>DHE</term><def><p>dihydroethidium</p></def></def-item><def-item><term>DTPA</term><def><p>diethylenetriaminepentaacetic acid</p></def></def-item><def-item><term>MMP</term><def><p>mitochondrial membrane potential</p></def></def-item><def-item><term>PD</term><def><p>Parkinson's disease</p></def></def-item><def-item><term>PS</term><def><p>phosphatidylserine</p></def></def-item><def-item><term>PLA<sub>2</sub></term><def><p>phospholipase A<sub>2</sub></p></def></def-item><def-item><term>PLA<sub>1</sub></term><def><p>phospholipase A<sub>1</sub></p></def></def-item><def-item><term>ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term>TLCL</term><def><p>tetra-linoleyl-cardiolipin</p></def></def-item><def-item><term>TMCL</term><def><p>tetra-myristoyl-cardiolipin</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="R1"><label>[1]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>B</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Parkinson's disease</article-title><source>Human molecular genetics</source><year>2007</year><volume>16</volume><issue>Spec No. 2</issue><fpage>R183</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">17911161</pub-id></element-citation></ref><ref id="R2"><label>[2]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schapira</surname><given-names>AH</given-names></name></person-group><article-title>Evidence for mitochondrial dysfunction in Parkinson's disease--a critical appraisal</article-title><source>Mov Disord</source><year>1994</year><volume>9</volume><fpage>125</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">8196673</pub-id></element-citation></ref><ref id="R3"><label>[3]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukae</surname><given-names>J</given-names></name><name><surname>Mizuno</surname><given-names>Y</given-names></name><name><surname>Hattori</surname><given-names>N</given-names></name></person-group><article-title>Mitochondrial dysfunction in Parkinson's disease</article-title><source>Mitochondrion</source><year>2007</year><volume>7</volume><fpage>58</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">17300997</pub-id></element-citation></ref><ref id="R4"><label>[4]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winklhofer</surname><given-names>KF</given-names></name><name><surname>Haass</surname><given-names>C</given-names></name></person-group><article-title>Mitochondrial dysfunction in Parkinson's disease</article-title><source>Biochim Biophys Acta</source><year>2010</year><volume>1802</volume><fpage>29</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">19733240</pub-id></element-citation></ref><ref id="R5"><label>[5]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>E</given-names></name><name><surname>Polidori</surname><given-names>MC</given-names></name><name><surname>Cherubini</surname><given-names>A</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name></person-group><article-title>Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview</article-title><source>J Chromatogr B Analyt Technol Biomed Life Sci</source><year>2005</year><volume>827</volume><fpage>65</fpage><lpage>75</lpage></element-citation></ref><ref id="R6"><label>[6]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>RC</given-names></name><name><surname>Lockwood</surname><given-names>AH</given-names></name><name><surname>Sonawane</surname><given-names>BR</given-names></name></person-group><article-title>Neurodegenerative diseases: an overview of environmental risk factors</article-title><source>Environ Health Perspect</source><year>2005</year><volume>113</volume><fpage>1250</fpage><lpage>1256</lpage><pub-id pub-id-type="pmid">16140637</pub-id></element-citation></ref><ref id="R7"><label>[7]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>C</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><name><surname>Nicotera</surname><given-names>P</given-names></name></person-group><article-title>Paraquat and Parkinson's disease</article-title><source>Cell Death Differ</source><year>2010</year><volume>17</volume><fpage>1115</fpage><lpage>1125</lpage><pub-id pub-id-type="pmid">20094060</pub-id></element-citation></ref><ref id="R8"><label>[8]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Migliore</surname><given-names>L</given-names></name><name><surname>Petrozzi</surname><given-names>L</given-names></name><name><surname>Lucetti</surname><given-names>C</given-names></name><name><surname>Gambaccini</surname><given-names>G</given-names></name><etal/></person-group><article-title>Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients</article-title><source>Neurology</source><year>2002</year><volume>58</volume><fpage>1809</fpage><lpage>1815</lpage><pub-id pub-id-type="pmid">12084881</pub-id></element-citation></ref><ref id="R9"><label>[9]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez</surname><given-names>C</given-names></name><name><surname>Bandez</surname><given-names>MJ</given-names></name><name><surname>Navarro</surname><given-names>A</given-names></name></person-group><article-title>Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome</article-title><source>Front Biosci</source><year>2007</year><volume>12</volume><fpage>1079</fpage><lpage>1093</lpage><pub-id pub-id-type="pmid">17127363</pub-id></element-citation></ref><ref id="R10"><label>[10]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avila-Gomez</surname><given-names>IC</given-names></name><name><surname>Velez-Pardo</surname><given-names>C</given-names></name><name><surname>Jimenez-Del-Rio</surname><given-names>M</given-names></name></person-group><article-title>Effects of insulin-like growth factor-1 on rotenone-induced apoptosis in human lymphocyte cells</article-title><source>Basic Clin Pharmacol Toxicol</source><year>2010</year><volume>106</volume><fpage>53</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">19874289</pub-id></element-citation></ref><ref id="R11"><label>[11]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drechsel</surname><given-names>DA</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name></person-group><article-title>Role of reactive oxygen species in the neurotoxicity of environmental agents implicated in Parkinson's disease</article-title><source>Free Radic Biol Med</source><year>2008</year><volume>44</volume><fpage>1873</fpage><lpage>1886</lpage><pub-id pub-id-type="pmid">18342017</pub-id></element-citation></ref><ref id="R12"><label>[12]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondrial dysfunction in movement disorders</article-title><source>Curr Opin Neurol</source><year>1994</year><volume>7</volume><fpage>333</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">7952242</pub-id></element-citation></ref><ref id="R13"><label>[13]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinde</surname><given-names>S</given-names></name><name><surname>Pasupathy</surname><given-names>K</given-names></name></person-group><article-title>Respiratory-chain enzyme activities in isolated mitochondria of lymphocytes from patients with Parkinson's disease: preliminary study</article-title><source>Neurol India</source><year>2006</year><volume>54</volume><fpage>390</fpage><lpage>393</lpage><pub-id pub-id-type="pmid">17114849</pub-id></element-citation></ref><ref id="R14"><label>[14]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Jeon</surname><given-names>BS</given-names></name><name><surname>Heo</surname><given-names>C</given-names></name><name><surname>Im</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Alpha-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease</article-title><source>FASEB J</source><year>2004</year><volume>18</volume><fpage>1615</fpage><lpage>1617</lpage><pub-id pub-id-type="pmid">15289452</pub-id></element-citation></ref><ref id="R15"><label>[15]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blandini</surname><given-names>F</given-names></name><name><surname>Sinforiani</surname><given-names>E</given-names></name><name><surname>Pacchetti</surname><given-names>C</given-names></name><name><surname>Samuele</surname><given-names>A</given-names></name><etal/></person-group><article-title>Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease</article-title><source>Neurology</source><year>2006</year><volume>66</volume><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">16505307</pub-id></element-citation></ref><ref id="R16"><label>[16]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calopa</surname><given-names>M</given-names></name><name><surname>Bas</surname><given-names>J</given-names></name><name><surname>Callen</surname><given-names>A</given-names></name><name><surname>Mestre</surname><given-names>M</given-names></name></person-group><article-title>Apoptosis of peripheral blood lymphocytes in Parkinson patients</article-title><source>Neurobiol Dis</source><year>2010</year><volume>38</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20044003</pub-id></element-citation></ref><ref id="R17"><label>[17]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><name><surname>Mnuskin</surname><given-names>A</given-names></name><etal/></person-group><article-title>Mass-spectrometric characterization of phospholipids and their primary peroxidation products in rat cortical neurons during staurosporine-induced apoptosis</article-title><source>Journal of neurochemistry</source><year>2008</year><volume>107</volume><fpage>1614</fpage><lpage>1633</lpage><pub-id pub-id-type="pmid">19014376</pub-id></element-citation></ref><ref id="R18"><label>[18]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Feng</surname><given-names>W</given-names></name><etal/></person-group><article-title>Mitochondrial injury after mechanical stretch of cortical neurons in vitro: biomarkers of apoptosis and selective peroxidation of anionic phospholipids</article-title><source>Journal of neurotrauma</source><year>2012</year><volume>29</volume><fpage>776</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">21895519</pub-id></element-citation></ref><ref id="R19"><label>[19]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayir</surname><given-names>H</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Viner</surname><given-names>R</given-names></name><etal/></person-group><article-title>Selective early cardiolipin peroxidation after traumatic brain injury: an oxidative lipidomics analysis</article-title><source>Annals of neurology</source><year>2007</year><volume>62</volume><fpage>154</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">17685468</pub-id></element-citation></ref><ref id="R20"><label>[20]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>J</given-names></name><name><surname>Kline</surname><given-names>AE</given-names></name><name><surname>Amoscato</surname><given-names>A</given-names></name><name><surname>Samhan-Arias</surname><given-names>AK</given-names></name><etal/></person-group><article-title>Lipidomics identifies cardiolipin oxidation as a mitochondrial target for redox therapy of brain injury</article-title><source>Nature neuroscience</source><year>2012</year><volume>15</volume><fpage>1407</fpage><lpage>1413</lpage></element-citation></ref><ref id="R21"><label>[21]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlame</surname><given-names>M</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name></person-group><article-title>The role of cardiolipin in the structural organization of mitochondrial membranes</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1788</volume><fpage>2080</fpage><lpage>2083</lpage><pub-id pub-id-type="pmid">19413994</pub-id></element-citation></ref><ref id="R22"><label>[22]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daum</surname><given-names>G</given-names></name><name><surname>Lees</surname><given-names>ND</given-names></name><name><surname>Bard</surname><given-names>M</given-names></name><name><surname>Dickson</surname><given-names>R</given-names></name></person-group><article-title>Biochemistry, cell biology and molecular biology of lipids of Saccharomyces cerevisiae</article-title><source>Yeast</source><year>1998</year><volume>14</volume><fpage>1471</fpage><lpage>1510</lpage><pub-id pub-id-type="pmid">9885152</pub-id></element-citation></ref><ref id="R23"><label>[23]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>DE</given-names></name></person-group><article-title>Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain</article-title><source>J Biol Chem</source><year>1981</year><volume>256</volume><fpage>1874</fpage><lpage>1880</lpage><pub-id pub-id-type="pmid">6257690</pub-id></element-citation></ref><ref id="R24"><label>[24]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharpley</surname><given-names>MS</given-names></name><name><surname>Shannon</surname><given-names>RJ</given-names></name><name><surname>Draghi</surname><given-names>F</given-names></name><name><surname>Hirst</surname><given-names>J</given-names></name></person-group><article-title>Interactions between phospholipids and NADH:ubiquinone oxidoreductase (complex I) from bovine mitochondria</article-title><source>Biochemistry</source><year>2006</year><volume>45</volume><fpage>241</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">16388600</pub-id></element-citation></ref><ref id="R25"><label>[25]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>NC</given-names></name></person-group><article-title>Functional binding of cardiolipin to cytochrome c oxidase</article-title><source>J Bioenerg Biomembr</source><year>1993</year><volume>25</volume><fpage>153</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">8389748</pub-id></element-citation></ref><ref id="R26"><label>[26]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eble</surname><given-names>KS</given-names></name><name><surname>Coleman</surname><given-names>WB</given-names></name><name><surname>Hantgan</surname><given-names>RR</given-names></name><name><surname>Cunningham</surname><given-names>CC</given-names></name></person-group><article-title>Tightly associated cardiolipin in the bovine heart mitochondrial ATP synthase as analyzed by 31P nuclear magnetic resonance spectroscopy</article-title><source>J Biol Chem</source><year>1990</year><volume>265</volume><fpage>19434</fpage><lpage>19440</lpage><pub-id pub-id-type="pmid">2147180</pub-id></element-citation></ref><ref id="R27"><label>[27]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Checkoway</surname><given-names>H</given-names></name><name><surname>Costa</surname><given-names>LG</given-names></name><name><surname>Woods</surname><given-names>JS</given-names></name><name><surname>Castoldi</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Peripheral blood cell activities of monoamine oxidase B and superoxide dismutase in Parkinson's disease</article-title><source>J Neural Transm Park Dis Dement Sect</source><year>1992</year><volume>4</volume><fpage>283</fpage><lpage>290</lpage><pub-id pub-id-type="pmid">1388699</pub-id></element-citation></ref><ref id="R28"><label>[28]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colombo</surname><given-names>C</given-names></name><name><surname>Cosentino</surname><given-names>M</given-names></name><name><surname>Marino</surname><given-names>F</given-names></name><name><surname>Rasini</surname><given-names>E</given-names></name><etal/></person-group><article-title>Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson's disease</article-title><source>Ann N Y Acad Sci</source><year>2003</year><volume>1010</volume><fpage>679</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">15033811</pub-id></element-citation></ref><ref id="R29"><label>[29]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amenta</surname><given-names>F</given-names></name><name><surname>Bronzetti</surname><given-names>E</given-names></name><name><surname>Cantalamessa</surname><given-names>F</given-names></name><name><surname>El-Assouad</surname><given-names>D</given-names></name><etal/></person-group><article-title>Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes</article-title><source>J Neuroimmunol</source><year>2001</year><volume>117</volume><fpage>133</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">11431013</pub-id></element-citation></ref><ref id="R30"><label>[30]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ridings</surname><given-names>J</given-names></name><name><surname>Weedon</surname><given-names>H</given-names></name><name><surname>Ioannou</surname><given-names>C</given-names></name><name><surname>Flego</surname><given-names>L</given-names></name><etal/></person-group><article-title>Purification of cord blood lymphocytes</article-title><source>Journal of immunological methods</source><year>1996</year><volume>195</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">8814318</pub-id></element-citation></ref><ref id="R31"><label>[31]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis</article-title><source>Free Radic Biol Med</source><year>2008</year><volume>44</volume><fpage>1935</fpage><lpage>1944</lpage><pub-id pub-id-type="pmid">18375209</pub-id></element-citation></ref><ref id="R32"><label>[32]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Wit</surname><given-names>LE</given-names></name><name><surname>Spruijt</surname><given-names>L</given-names></name><name><surname>Schoonderwoerd</surname><given-names>GC</given-names></name><name><surname>de Coo</surname><given-names>IF</given-names></name><etal/></person-group><article-title>A simplified and reliable assay for complex I in human blood lymphocytes</article-title><source>Journal of immunological methods</source><year>2007</year><volume>326</volume><fpage>76</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17706244</pub-id></element-citation></ref><ref id="R33"><label>[33]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieckowski</surname><given-names>MR</given-names></name><name><surname>Giorgi</surname><given-names>C</given-names></name><name><surname>Lebiedzinska</surname><given-names>M</given-names></name><name><surname>Duszynski</surname><given-names>J</given-names></name><name><surname>Pinton</surname><given-names>P</given-names></name></person-group><article-title>Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells</article-title><source>Nature protocols</source><year>2009</year><volume>4</volume><fpage>1582</fpage><lpage>1590</lpage></element-citation></ref><ref id="R34"><label>[34]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagan</surname><given-names>VE</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><etal/></person-group><article-title>Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors</article-title><source>Nat Chem Biol</source><year>2005</year><volume>1</volume><fpage>223</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">16408039</pub-id></element-citation></ref><ref id="R35"><label>[35]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folch</surname><given-names>J</given-names></name><name><surname>Lees</surname><given-names>M</given-names></name><name><surname>Sloane Stanley</surname><given-names>GH</given-names></name></person-group><article-title>A simple method for the isolation and purification of total lipides from animal tissues</article-title><source>J Biol Chem</source><year>1957</year><volume>226</volume><fpage>497</fpage><lpage>509</lpage><pub-id pub-id-type="pmid">13428781</pub-id></element-citation></ref><ref id="R36"><label>[36]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boettcher</surname><given-names>C</given-names></name><name><surname>Pries</surname><given-names>C</given-names></name><name><surname>Vangent</surname><given-names>CM</given-names></name></person-group><article-title>A Rapid and Sensitive Sub-Micro Phosphorus Determination</article-title><source>Anal Chim Acta</source><year>1961</year><volume>24</volume><fpage>203</fpage></element-citation></ref><ref id="R37"><label>[37]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Ritov</surname><given-names>VB</given-names></name><name><surname>Lysytsya</surname><given-names>A</given-names></name><etal/></person-group><article-title>Oxidative lipidomics of apoptosis: quantitative assessment of phospholipid hydroperoxides in cells and tissues</article-title><source>Methods Mol Biol</source><year>2010</year><volume>610</volume><fpage>353</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">20013189</pub-id></element-citation></ref><ref id="R38"><label>[38]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouser</surname><given-names>G</given-names></name><name><surname>Fkeischer</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>A</given-names></name></person-group><article-title>Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots</article-title><source>Lipids</source><year>1970</year><volume>5</volume><fpage>494</fpage><lpage>496</lpage><pub-id pub-id-type="pmid">5483450</pub-id></element-citation></ref><ref id="R39"><label>[39]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Kisin</surname><given-names>ER</given-names></name><name><surname>Murray</surname><given-names>A</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><etal/></person-group><article-title>Global phospholipidomics analysis reveals selective pulmonary peroxidation profiles upon inhalation of single-walled carbon nanotubes</article-title><source>ACS nano</source><year>2011</year><volume>5</volume><fpage>7342</fpage><lpage>7353</lpage><pub-id pub-id-type="pmid">21800898</pub-id></element-citation></ref><ref id="R40"><label>[40]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Hoppel</surname><given-names>CL</given-names></name></person-group><article-title>Monolysocardiolipin: improved preparation with high yield</article-title><source>J Lipid Res</source><year>2011</year><volume>52</volume><fpage>389</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">20959418</pub-id></element-citation></ref><ref id="R41"><label>[41]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>SH</given-names></name><name><surname>Jenkins</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Guan</surname><given-names>S</given-names></name><etal/></person-group><article-title>Activation of mitochondrial calcium-independent phospholipase A2gamma (iPLA2gamma) by divalent cations mediating arachidonate release and production of downstream eicosanoids</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>14880</fpage><lpage>14895</lpage><pub-id pub-id-type="pmid">22389508</pub-id></element-citation></ref><ref id="R42"><label>[42]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zachman</surname><given-names>DK</given-names></name><name><surname>Chicco</surname><given-names>AJ</given-names></name><name><surname>McCune</surname><given-names>SA</given-names></name><name><surname>Murphy</surname><given-names>RC</given-names></name><etal/></person-group><article-title>The role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heart</article-title><source>J Lipid Res</source><year>2010</year><volume>51</volume><fpage>525</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">19741254</pub-id></element-citation></ref><ref id="R43"><label>[43]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seleznev</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>XH</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>ZA</given-names></name></person-group><article-title>Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>22275</fpage><lpage>22288</lpage><pub-id pub-id-type="pmid">16728389</pub-id></element-citation></ref><ref id="R44"><label>[44]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>van der Heijden</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>van der Greef</surname><given-names>J</given-names></name><etal/></person-group><article-title>Analytical strategies in lipidomics and applications in disease biomarker discovery</article-title><source>J Chromatogr B Analyt Technol Biomed Life Sci</source><year>2009</year><volume>877</volume><fpage>2836</fpage><lpage>2846</lpage></element-citation></ref><ref id="R45"><label>[45]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>AH</given-names></name><name><surname>Chung</surname><given-names>KK</given-names></name></person-group><article-title>Oxidative and nitrosative stress in Parkinson's disease</article-title><source>Biochim Biophys Acta</source><year>2009</year><volume>1792</volume><fpage>643</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">19162179</pub-id></element-citation></ref><ref id="R46"><label>[46]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>A</given-names></name><name><surname>Boveris</surname><given-names>A</given-names></name></person-group><article-title>Brain mitochondrial dysfunction and oxidative damage in Parkinson's disease</article-title><source>J Bioenerg Biomembr</source><year>2009</year><volume>41</volume><fpage>517</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">19915964</pub-id></element-citation></ref><ref id="R47"><label>[47]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surendran</surname><given-names>S</given-names></name><name><surname>Rajasankar</surname><given-names>S</given-names></name></person-group><article-title>Parkinson's disease: oxidative stress and therapeutic approaches</article-title><source>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</source><year>2010</year><volume>31</volume><fpage>531</fpage><lpage>540</lpage></element-citation></ref><ref id="R48"><label>[48]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiperez</surname><given-names>V</given-names></name><name><surname>Darios</surname><given-names>F</given-names></name><name><surname>Davletov</surname><given-names>B</given-names></name></person-group><article-title>Alpha-synuclein, lipids and Parkinson's disease</article-title><source>Progress in lipid research</source><year>2010</year><volume>49</volume><fpage>420</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">20580911</pub-id></element-citation></ref><ref id="R49"><label>[49]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breusing</surname><given-names>N</given-names></name><name><surname>Grune</surname><given-names>T</given-names></name></person-group><article-title>Biomarkers of protein oxidation from a chemical, biological and medical point of view</article-title><source>Exp Gerontol</source><year>2010</year><volume>45</volume><fpage>733</fpage><lpage>737</lpage><pub-id pub-id-type="pmid">20403419</pub-id></element-citation></ref><ref id="R50"><label>[50]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Nemani</surname><given-names>VM</given-names></name><name><surname>Azarbal</surname><given-names>F</given-names></name><name><surname>Skibinski</surname><given-names>G</given-names></name><etal/></person-group><article-title>Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>20710</fpage><lpage>20726</lpage><pub-id pub-id-type="pmid">21489994</pub-id></element-citation></ref><ref id="R51"><label>[51]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benkler</surname><given-names>M</given-names></name><name><surname>Agmon-Levin</surname><given-names>N</given-names></name><name><surname>Hassin-Baer</surname><given-names>S</given-names></name><name><surname>Cohen</surname><given-names>OS</given-names></name><etal/></person-group><article-title>Immunology, autoimmunity, and autoantibodies in Parkinson's disease</article-title><source>Clinical reviews in allergy &#x00026; immunology</source><year>2012</year><volume>42</volume><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="pmid">21234712</pub-id></element-citation></ref><ref id="R52"><label>[52]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayir</surname><given-names>H</given-names></name><name><surname>Kapralov</surname><given-names>AA</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>15951</fpage><lpage>15969</lpage><pub-id pub-id-type="pmid">19351880</pub-id></element-citation></ref><ref id="R53"><label>[53]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradies</surname><given-names>G</given-names></name><name><surname>Ruggiero</surname><given-names>FM</given-names></name><name><surname>Dinoi</surname><given-names>P</given-names></name><name><surname>Petrosillo</surname><given-names>G</given-names></name><name><surname>Quagliariello</surname><given-names>E</given-names></name></person-group><article-title>Decreased cytochrome oxidase activity and changes in phospholipids in heart mitochondria from hypothyroid rats</article-title><source>Arch Biochem Biophys</source><year>1993</year><volume>307</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">8239670</pub-id></element-citation></ref><ref id="R54"><label>[54]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chicco</surname><given-names>AJ</given-names></name><name><surname>Sparagna</surname><given-names>GC</given-names></name></person-group><article-title>Role of cardiolipin alterations in mitochondrial dysfunction and disease</article-title><source>Am J Physiol Cell Physiol</source><year>2007</year><volume>292</volume><fpage>C33</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">16899548</pub-id></element-citation></ref><ref id="R55"><label>[55]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesnefsky</surname><given-names>EJ</given-names></name><name><surname>Hoppel</surname><given-names>CL</given-names></name></person-group><article-title>Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat</article-title><source>Biochim Biophys Acta</source><year>2008</year><volume>1777</volume><fpage>1020</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">18515061</pub-id></element-citation></ref><ref id="R56"><label>[56]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paradies</surname><given-names>G</given-names></name><name><surname>Petrosillo</surname><given-names>G</given-names></name><name><surname>Paradies</surname><given-names>V</given-names></name><name><surname>Ruggiero</surname><given-names>FM</given-names></name></person-group><article-title>Role of cardiolipin peroxidation and Ca2+ in mitochondrial dysfunction and disease</article-title><source>Cell Calcium</source><year>2009</year><volume>45</volume><fpage>643</fpage><lpage>650</lpage><pub-id pub-id-type="pmid">19368971</pub-id></element-citation></ref><ref id="R57"><label>[57]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>FY</given-names></name><name><surname>Taylor</surname><given-names>WA</given-names></name><name><surname>Hurd</surname><given-names>JA</given-names></name><name><surname>Hatch</surname><given-names>GM</given-names></name></person-group><article-title>Etomoxir mediates differential metabolic channeling of fatty acid and glycerol precursors into cardiolipin in H9c2 cells</article-title><source>J Lipid Res</source><year>2003</year><volume>44</volume><fpage>415</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">12576524</pub-id></element-citation></ref><ref id="R58"><label>[58]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Ren</surname><given-names>M</given-names></name><name><surname>Schlame</surname><given-names>M</given-names></name></person-group><article-title>The enzymatic function of tafazzin</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>39217</fpage><lpage>39224</lpage><pub-id pub-id-type="pmid">17082194</pub-id></element-citation></ref><ref id="R59"><label>[59]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Romestaing</surname><given-names>C</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity</article-title><source>Cell Metab</source><year>2010</year><volume>12</volume><fpage>154</fpage><lpage>165</lpage><pub-id pub-id-type="pmid">20674860</pub-id></element-citation></ref><ref id="R60"><label>[60]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>WA</given-names></name><name><surname>Xu</surname><given-names>FY</given-names></name><name><surname>Ma</surname><given-names>BJ</given-names></name><name><surname>Mutter</surname><given-names>TC</given-names></name><etal/></person-group><article-title>Expression of monolysocardiolipin acyltransferase activity is regulated in concert with the level of cardiolipin and cardiolipin biosynthesis in the mammalian heart</article-title><source>BMC Biochem</source><year>2002</year><volume>3</volume><fpage>9</fpage><pub-id pub-id-type="pmid">12019031</pub-id></element-citation></ref><ref id="R61"><label>[61]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Testa</surname><given-names>CM</given-names></name><name><surname>Sherer</surname><given-names>TB</given-names></name><name><surname>Greenamyre</surname><given-names>JT</given-names></name></person-group><article-title>Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures</article-title><source>Brain Res Mol Brain Res</source><year>2005</year><volume>134</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">15790535</pub-id></element-citation></ref><ref id="R62"><label>[62]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Z</given-names></name><name><surname>Wood</surname><given-names>NW</given-names></name></person-group><article-title>Cell death pathways in Parkinson's disease: role of mitochondria</article-title><source>Antioxid Redox Signal</source><year>2009</year><volume>11</volume><fpage>2135</fpage><lpage>2149</lpage><pub-id pub-id-type="pmid">19422283</pub-id></element-citation></ref><ref id="R63"><label>[63]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fiskum</surname><given-names>G</given-names></name><name><surname>Starkov</surname><given-names>A</given-names></name><name><surname>Polster</surname><given-names>BM</given-names></name><name><surname>Chinopoulos</surname><given-names>C</given-names></name></person-group><article-title>Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease</article-title><source>Ann N Y Acad Sci</source><year>2003</year><volume>991</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">12846980</pub-id></element-citation></ref><ref id="R64"><label>[64]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henchcliffe</surname><given-names>C</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis</article-title><source>Nat Clin Pract Neurol</source><year>2008</year><volume>4</volume><fpage>600</fpage><lpage>609</lpage><pub-id pub-id-type="pmid">18978800</pub-id></element-citation></ref><ref id="R65"><label>[65]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CM</given-names></name><name><surname>Liu</surname><given-names>JL</given-names></name><name><surname>Wu</surname><given-names>YR</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><etal/></person-group><article-title>Increased oxidative damage in peripheral blood correlates with severity of Parkinson's disease</article-title><source>Neurobiol Dis</source><year>2009</year><volume>33</volume><fpage>429</fpage><lpage>435</lpage><pub-id pub-id-type="pmid">19110057</pub-id></element-citation></ref><ref id="R66"><label>[66]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leuner</surname><given-names>K</given-names></name><name><surname>Schulz</surname><given-names>K</given-names></name><name><surname>Schutt</surname><given-names>T</given-names></name><name><surname>Pantel</surname><given-names>J</given-names></name><etal/></person-group><article-title>Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes</article-title><source>Molecular neurobiology</source><year>2012</year><volume>46</volume><fpage>194</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">22821186</pub-id></element-citation></ref><ref id="R67"><label>[67]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatta</surname><given-names>L</given-names></name><name><surname>Cardinale</surname><given-names>A</given-names></name><name><surname>Wannenes</surname><given-names>F</given-names></name><name><surname>Consoli</surname><given-names>C</given-names></name><etal/></person-group><article-title>Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs</article-title><source>Neurosci Lett</source><year>2009</year><volume>453</volume><fpage>36</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">19429011</pub-id></element-citation></ref><ref id="R68"><label>[68]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name></person-group><article-title>Apoptosis signaling pathways and lymphocyte homeostasis</article-title><source>Cell Res</source><year>2007</year><volume>17</volume><fpage>759</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">17576411</pub-id></element-citation></ref><ref id="R69"><label>[69]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genova</surname><given-names>ML</given-names></name><name><surname>Pich</surname><given-names>MM</given-names></name><name><surname>Bernacchia</surname><given-names>A</given-names></name><name><surname>Bianchi</surname><given-names>C</given-names></name><etal/></person-group><article-title>The mitochondrial production of reactive oxygen species in relation to aging and pathology</article-title><source>Ann N Y Acad Sci</source><year>2004</year><volume>1011</volume><fpage>86</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">15126287</pub-id></element-citation></ref><ref id="R70"><label>[70]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>BB</given-names></name><name><surname>Marella</surname><given-names>M</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Matsuno-Yagi</surname><given-names>A</given-names></name></person-group><article-title>The single subunit NADH dehydrogenase reduces generation of reactive oxygen species from complex I</article-title><source>FEBS letters</source><year>2006</year><volume>580</volume><fpage>6105</fpage><lpage>6108</lpage><pub-id pub-id-type="pmid">17055488</pub-id></element-citation></ref><ref id="R71"><label>[71]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Epperly</surname><given-names>MW</given-names></name><name><surname>Greenberger</surname><given-names>JS</given-names></name><name><surname>Kagan</surname><given-names>VE</given-names></name></person-group><article-title>Oxidative lipidomics of gamma-irradiation-induced intestinal injury</article-title><source>Free Radic Biol Med</source><year>2008</year><volume>44</volume><fpage>299</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">18215738</pub-id></element-citation></ref><ref id="R72"><label>[72]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyurina</surname><given-names>YY</given-names></name><name><surname>Tyurin</surname><given-names>VA</given-names></name><name><surname>Kaynar</surname><given-names>AM</given-names></name><name><surname>Kapralova</surname><given-names>VI</given-names></name><etal/></person-group><article-title>Oxidative lipidomics of hyperoxic acute lung injury: mass spectrometric characterization of cardiolipin and phosphatidylserine peroxidation</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2010</year><volume>299</volume><fpage>L73</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">20418384</pub-id></element-citation></ref><ref id="R73"><label>[73]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patriarca</surname><given-names>A</given-names></name><name><surname>Polticelli</surname><given-names>F</given-names></name><name><surname>Piro</surname><given-names>MC</given-names></name><name><surname>Sinibaldi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Conversion of cytochrome c into a peroxidase: inhibitory mechanisms and implication for neurodegenerative diseases</article-title><source>Arch Biochem Biophys</source><year>2012</year><volume>522</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">22507899</pub-id></element-citation></ref><ref id="R74"><label>[74]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Everse</surname><given-names>J</given-names></name><name><surname>Coates</surname><given-names>PW</given-names></name></person-group><article-title>Neurodegeneration and peroxidases</article-title><source>Neurobiology of aging</source><year>2009</year><volume>30</volume><fpage>1011</fpage><lpage>1025</lpage><pub-id pub-id-type="pmid">18053617</pub-id></element-citation></ref><ref id="R75"><label>[75]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teismann</surname><given-names>P</given-names></name></person-group><article-title>COX-2 in the neurodegenerative process of Parkinson's disease</article-title><source>BioFactors</source><year>2012</year></element-citation></ref><ref id="R76"><label>[76]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jezek</surname><given-names>J</given-names></name><name><surname>Jaburek</surname><given-names>M</given-names></name><name><surname>Zelenka</surname><given-names>J</given-names></name><name><surname>Jezek</surname><given-names>P</given-names></name></person-group><article-title>Mitochondrial phospholipase A2 activated by reactive oxygen species in heart mitochondria induces mild uncoupling</article-title><source>Physiological research / Academia Scientiarum Bohemoslovaca</source><year>2010</year><volume>59</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="pmid">20406040</pub-id></element-citation></ref><ref id="R77"><label>[77]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brustovetsky</surname><given-names>T</given-names></name><name><surname>Antonsson</surname><given-names>B</given-names></name><name><surname>Jemmerson</surname><given-names>R</given-names></name><name><surname>Dubinsky</surname><given-names>JM</given-names></name><name><surname>Brustovetsky</surname><given-names>N</given-names></name></person-group><article-title>Activation of calcium-independent phospholipase A (iPLA) in brain mitochondria and release of apoptogenic factors by BAX and truncated BID</article-title><source>Journal of neurochemistry</source><year>2005</year><volume>94</volume><fpage>980</fpage><lpage>994</lpage><pub-id pub-id-type="pmid">16092941</pub-id></element-citation></ref><ref id="R78"><label>[78]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowron</surname><given-names>A</given-names></name><name><surname>Frost</surname><given-names>R</given-names></name><name><surname>Powers</surname><given-names>VE</given-names></name><name><surname>Thomas</surname><given-names>PH</given-names></name><etal/></person-group><article-title>Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis</article-title><source>Journal of inherited metabolic disease</source><year>2012</year></element-citation></ref><ref id="R79"><label>[79]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>RJ</given-names></name><name><surname>Schulz</surname><given-names>JB</given-names></name><name><surname>Kowall</surname><given-names>NW</given-names></name><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Systemic administration of rotenone produces selective damage in the striatum and globus pallidus, but not in the substantia nigra</article-title><source>Brain research</source><year>1997</year><volume>753</volume><fpage>157</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">9125443</pub-id></element-citation></ref><ref id="R80"><label>[80]</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Betarbet</surname><given-names>R</given-names></name><name><surname>Sherer</surname><given-names>TB</given-names></name><name><surname>MacKenzie</surname><given-names>G</given-names></name><name><surname>Garcia-Osuna</surname><given-names>M</given-names></name><etal/></person-group><article-title>Chronic systemic pesticide exposure reproduces features of Parkinson's disease</article-title><source>Nature neuroscience</source><year>2000</year><volume>3</volume><fpage>1301</fpage><lpage>1306</lpage></element-citation></ref></ref-list></back><floats-group><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Effects of rotenone on mitochondrial functions in human peripheral blood lymphocytes</title><p>Complex I activity (A), MMP (B) and content of ATP (C) in human lymphocytes exposed to rotenone (100, 250 &#x003bc;M, 12 and 18 hrs at 37&#x000b0;C). Typical fluorescent images of control and rotenone-treated lymphocytes (B,a) and assessment of MMP by using flow cytometry (B,b). Data are means &#x000b1; S.E., n=6, *p&#x0003c;0.05 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0001"/></fig><fig id="F2" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Rotenone induced generation of reactive oxygen species generated in human peropheral blood lymphocytes</title><p>Superoxide (A) and hydrogen peroxide (B) formation in lymphocytes exposed to rotenone (100 and 250 &#x003bc;M for 12 and 18 hrs at 37&#x000b0;C). Data are means &#x000b1; S.E., n=6, *p&#x0003c;0.05 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0002"/></fig><fig id="F3" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Apoptosis induced by rotenone in human peripheral blood lymphocytes</title><p>Caspase 3/7 activation (A) and PS externalization (B) in lymphocytes exposed to rotenone (100 and 250 &#x003bc;M for 12 and 18 hrs, at 37&#x000b0;C). Data are means &#x000b1; S.E., n=6, *p&#x0003c;0.05 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0003"/></fig><fig id="F4" orientation="portrait" position="float"><label>Figure 4</label><caption><title>Peroxidase activity of mitochondria isolated from human peripheral blood lymphocytes</title><p>Mitochondria were isolated from lymphocytes exposed to rotenone (100 and 250 &#x003bc;M for 18 hrs, at 37&#x000b0;C) treated with alamethicin and peroxidase activity was detected. Data are means &#x000b1; S.E., n=3, *p&#x0003c;0.05 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0004"/></fig><fig id="F5" orientation="portrait" position="float"><label>Figure 5</label><caption><title>Rotenone induced oxidation of CL in human peripheral blood lymphocytes</title><p>Typical negative mode ESI-MS spectrum of CL obtained from human lymphocytes (A), LC/MS quantitative assessment of TLCL (B) and oxidized (C) TLCL molecular species. Note: the decrease of TLCL and accumulation of its oxygenated species were dependent on rotenone concentration. Oxygenated molecular species of TLCL with m/z 1464 (plus 1 oxygen), 1480 (plus two oxygens) and 1496 (plus three oxygens) were detected in rotenone treated lymphocytes (18 hrs). Data are means &#x000b1; S.E., n=5, *p&#x0003c;0.03 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0005"/></fig><fig id="F6" orientation="portrait" position="float"><label>Figure 6</label><caption><title>Identification of esterified oxygenated fatty acids in human peripheral blood lymphocytes esposed to rotenone</title><p>Quantitative LC/MS assessment of oxygenated C<sub>18:2</sub> localized and <italic>sn</italic>-1 (A) and <italic>sn</italic>-2 (B) positions of CL from rotenone-exposed lymphocytes (100 and 250 &#x003bc;M, for 18 hrs at 37&#x000b0;C. (a) Decrease of oxidizable C<sub>18:2</sub> and (b) formation of oxygenated C<sub>18:2</sub> hydrolyzed from <italic>sn</italic>-1 and <italic>sn</italic>-2 positions of CL, respectively. Data are means &#x000b1; S.E., n=5, *p&#x0003c;0.03 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0006"/></fig><fig id="F7" orientation="portrait" position="float"><label>Figure 7</label><caption><title>Cyt c induced oxidation of TLCL in the presence of H<sub>2</sub>O<sub>2</sub></title><p>Quantitative LC/MS assessment of TLCL and its oxygenated species (A) formed in cyt <italic>c</italic> driven reaction. Oxygenated products of C<sub>18:2</sub> (B) formed in <italic>sn</italic>-1 (a) and <italic>sn</italic>-2 (b) positions of CL upon treatment of TLCL with cyt c/H<sub>2</sub>O<sub>2</sub>. After incubation with cyt c/H<sub>2</sub>O<sub>2</sub>, TLCL was treated either with PLA<sub>1</sub> or PLA<sub>2</sub>. Liberated oxygenated and non-oxygenated C<sub>18:2</sub> were analyzed by reverse phase LC/MS. Data are means &#x000b1; S.E., n=5, *p&#x0003c;0.05 <italic>vs</italic> control.</p></caption><graphic xlink:href="nihms-515225-f0007"/></fig><fig id="F8" orientation="portrait" position="float"><label>Figure 8</label><caption><title>Rotenone induced accumulation of mono-lyso-CL and oxygenated free fatty acids in human peripheral blood lymphocytes</title><p>(A) LC/MS base profile (a) and quantitative assessment (b) of mono-lyso-CL. (B) Content of free C18:2 containing one (a) two (b) and three (c) oxygens in lymphocytes treated with rotenone (100 and 250 &#x003bc;M for 18 hrs at 37&#x000b0;C. Note: the increase of mono-lyso-CL was accompanied by accumulation of oxygenated free C<sub>18:2</sub>. Data are means &#x000b1; S.E., n=5, *p&#x0003c;0.05 vs control.</p></caption><graphic xlink:href="nihms-515225-f0008"/></fig><fig id="F9" orientation="portrait" position="float"><label>Figure 9</label><caption><title>Proposed mechanism of rotenone-induced CL oxidation and its hydrolysis in human lymphocytes mitochondria</title><p>IMM-inner mitochondrial membrane; cyt <italic>c</italic>, cytochrome <italic>c</italic>; iPLA<sub>2</sub>- Ca<sup>2+</sup>-independent phospholipase A<sub>2</sub>; CL, cardiolipin; CLox, oxygenated cardiolipin; mCL, monolyso-cardiolipin; FAox, oxygenated C<sub>18:2</sub>.</p></caption><graphic xlink:href="nihms-515225-f0009"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Identification and quantitative assessment of major CL molecular species in human peripheral blood lymphocytes by LC/MS</p></caption><table frame="box" rules="all"><thead><tr><th align="center" valign="middle" rowspan="1" colspan="1">m/z</th><th align="center" valign="middle" rowspan="1" colspan="1">Molecular species</th><th align="center" valign="middle" rowspan="1" colspan="1">pmol/nmol CL</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">1421.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>16:1</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">30.5 &#x000b1; 7.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1447.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">632.0 &#x000b1; 24.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1449.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:1</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">147.1 &#x000b1; 6.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1469.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>20:5</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">46.8 &#x000b1; 3.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1471.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>20:4</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">49.0 &#x000b1; 7.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1473.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>20:3</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">96.2 &#x000b1; 11.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1475.9</td><td align="center" valign="middle" rowspan="1" colspan="1">C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>18:2</sub>/C<sub>20:2</sub></td><td align="center" valign="middle" rowspan="1" colspan="1">54.3 &#x000b1; 5.5</td></tr></tbody></table><table-wrap-foot><p>Data are means &#x000b1; SD, n=5.</p></table-wrap-foot></table-wrap></floats-group></article>